Detalhe da pesquisa
1.
New Research Aims to Optimize Therapy Against Onchocerciasis.
Mo Med;
119(1): 55-59, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36033145
2.
Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
Lancet;
392(10154): 1207-1216, 2018 10 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29361335
3.
Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia.
Parasit Vectors;
17(1): 137, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38491528
4.
The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registration.
Parasit Vectors;
16(1): 82, 2023 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36859332
5.
The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use.
Parasit Vectors;
16(1): 394, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37907954
6.
A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.
PLoS Negl Trop Dis;
17(5): e0011365, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37205721
7.
Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?
Philos Trans R Soc Lond B Biol Sci;
378(1887): 20220277, 2023 10 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37598705
8.
Effect of a single dose of 8 mg moxidectin or 150 µg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection.
PLoS Negl Trop Dis;
16(4): e0010079, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35476631
9.
A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana.
Am J Trop Med Hyg;
106(2): 740-745, 2021 11 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34844204
10.
Response to the Letter to the Editor by Eberhard et al.
Parasit Vectors;
10(1): 240, 2017 05 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28511662
11.
Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings.
Parasit Vectors;
9(1): 343, 2016 06 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27301567
12.
Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.
Parasit Vectors;
8: 515, 2015 Oct 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26452723
13.
The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data.
Parasit Vectors;
8: 167, 2015 Mar 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25889256
14.
A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.
PLoS Negl Trop Dis;
8(6): e2953, 2014 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24968000